▲ Peaking
Business
🔮 PULSE predicts: fades by tomorrow
Revolution Medicines shares promising data around KRAS drug combination
5sources
5articles
3velocity
+0%since first seen
1h agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (5)
- Anirban Maitra։ Data on Zoldonrasib Plus Daraxonrasib in 2nd and 3rd Line Metastatic Pancreatic Cancer Oncodaily · 1d ago
- Practice-Changing Data in GI Oncology Medscape · 1d ago
- Revolution Medicines Presents Phase 1/2 Clinical Data for Zoldonrasib Combination Regimens in Patients with RAS G12D Metastatic Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026 Yahoo Finance · 1d ago
- Experimental cancer drug brings time and hope for patients WSAW · 1d ago
- Revolution Medicines shares promising data around KRAS drug combination Endpoints News · 1d ago
Related trends
▲ Peaking
Business
🔮 fades
Baltimore Gas and Electric seeks $8 monthly rate increase for Maryland customers
▲ Peaking
Business
🔮 fades
Jim Farley Wants Ford’s Rivals Punished For Importing Nearly Half The Cars They Sell Here
▲ Peaking
Business
🔮 fades
Global stock markets close higher as Europe's benchmark hits 52-week high: Live updates
▲ Peaking
Business
🔮 fades
Dow Jones Futures: Tech Futures' Rise Show AI Bulls Still Fighting; Apple, Robinhood Flash Buy Signals
▲ Peaking
Business
🔮 fades
58 Fourth of July Food Deals Worthy of Celebration: Free Beer, Doughnuts and More
↑ Rising
Business
🔮 fades
United Airlines invests in Chicago with new O’Hare terminal and more jobs - WGN-TV
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.